Syndax Pharmaceuticals Inc. (SNDX) ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a ...

Repligen expects full-year earnings in the range of $1.67 to $1.76 per share, with revenue in the range of $685 million to $710 million. This story was generated by Automated Insights ( ...

Waltham, Massachusetts-based Revvity ... $138.24 represents a 20.5% premium to RVTY’s current price levels. The Street-high price target of $155 suggests an upside potential of 35.1%.

The Waltham, Massachusetts-based company said it had a loss of 81 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...

Veralto Corporation (VLTO), headquartered in Waltham, Massachusetts ... Its adjusted EPS of $0.95 surpassed Wall Street expectations of $0.88. The company’s revenue was $1.4 billion, topping ...